Infant Bacterial Therapeutics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021
For the full year, net loss was SEK 44.99 million compared to SEK 72.01 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
98.6 SEK | -2.38% |
|
+2.71% | +9.56% |
Jul. 08 | Infant Bacterial Therapeutics AB Completes Clinical Development Program | CI |
May. 07 | Infant Bacterial Therapeutics AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+9.56% | 126M | |
+5.31% | 72.01B | |
+31.27% | 10.39B | |
+41.28% | 5.26B | |
-18.53% | 4.64B | |
+18.24% | 3.7B | |
+26.86% | 2.3B | |
-39.52% | 1.8B | |
-45.54% | 1.7B | |
-0.50% | 1.64B |